ArticleBMC psychology2025
Validation of the Chinese version of the 12-Item multiple sclerosis walking scale in individuals with multiple sclerosis: a psychometric and item response theory analysis.
Article in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe 12-item Multiple Sclerosis Walking Scale (MSWS-12) is widely used to assess patient-perceived walking disability in individuals with multiple sclerosis (MS). Despite its international application, a validated Mandarin version has been lacking. This study aimed to translate and validate the Chinese version of the MSWS-12 and examine its psychometric properties using both classical test theory (CTT) and item response theory (IRT) approaches.
methodsThe MSWS-12 was translated into Chinese following international guidelines, including forward and backward translation, expert panel review, and cognitive debriefing. Cognitive debriefing was conducted with 20 individuals with MS (10 urban, 10 rural; 40% with a high school education or lower), confirming that all items were clear, culturally relevant, and conceptually equivalent. Participants were recruited from neurology clinics and included adults with clinically confirmed MS who had sufficient cognitive and physical function to complete the self-report instrument. Measurement properties were evaluated in accordance with the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guideline, including internal consistency, test-retest reliability, structural validity, measurement invariance, and item-level analysis using the Graded Response Model (GRM).
resultsParticipants (N = 292) had a mean age of 41.72 years (SD = 5.23), with 60.6% identifying as female, and represented a diverse educational backgrounds. The Chinese version of the MSWS-12 demonstrated excellent internal consistency (Cronbach's α = 0.92; McDonald's ω = 0.91) and strong test-retest reliability (intraclass correlation coefficient [ICC] = 0.91, 95% CI [0.86, 0.94]), indicating high temporal stability. CFA supported a unidimensional structure with excellent model fit (CFI = 0.987, TLI = 0.984, IFI = 0.987, SRMR = 0.032, RMSEA = 0.038. 90% CI [0.015, 0.056]). Measurement invariance was confirmed across sex, residency, and disease duration at configural, metric, scalar, and strict levels (ΔCFI < 0.010, ΔRMSEA < 0.015). IRT analysis showed high item discrimination parameters (α = 2.01 - 2.95) and well-ordered respnse thresholds. No evidence of differential item functioning (DIF) was found (Δpseudo-R² < 0.02). Criterion-related validity was supported by strong correlations with the T25FW (r = .64, 95% CI [0.57, 0.70]) and the 6MWT (r = -.61, 95% CI [-0.67, -0.53]). Convergent validity was indicated by moderate associations with the EDSS (r = .47, 95% CI [0.37, 0.55]) and the MFIS (r = .45, 95% CI [0.36, 0.54]), while discriminant validity was confirmed by a weak association with the PHQ-9 (r = .28, 95% CI [0.17, 0.38]).
conclusionThe Chinese version of the MSWS-12 is a psychometrically sound, culturally valid tool for assessing ambulatory disability in Mandarin-speaking individuals with MS. Its demonstrated reliability, validity, and measurement invariance support its application in clinical practice and cross-cultural research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.